Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study

  1. Grill, J.
  2. Geoerger, B.
  3. Gesner, L.
  4. Perek, D.
  5. Leblond, P.
  6. Cañete, A.
  7. Aerts, I.
  8. Madero, L.
  9. De Toledo Codina, J.S.
  10. Verlooy, J.
  11. Estlin, E.
  12. Cisar, L.
  13. Breazna, A.
  14. Dorman, A.
  15. Bailey, S.
  16. Nicolin, G.
  17. Grundy, R.G.
  18. Hargrave, D.
Aldizkaria:
Neuro-Oncology

ISSN: 1522-8517,  1523-5866

Argitalpen urtea: 2013

Alea: 15

Zenbakia: 9

Orrialdeak: 1236-1243

Mota: Artikulua

DOI: 10.1093/NEUONC/NOT097 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus